Clinical Trials Browser

Phase 2 × INDUSTRY × Disease × Clear all

NCT07216443 2026-02-23

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase 2 Recruiting

MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

NCT04410367 2025-07-20

PURSUE

Phase 2 Completed

23 enrolled 10 charts

Brain Neoplasms, Disease

NCT02798406 2021-07-15

CAPTIVE

Phase 2 Completed

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Phase 2 Completed

126 enrolled 12 charts

Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

NCT00332969 2017-03-31

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Phase 2 Completed

Disease, Neoplasms, Thymoma

NCT01620359 2016-08-31

Study of ExAblate Focused Ultrasound Ablation of Breast Cancer

Phase 2 Completed

Breast Neoplasms, Disease

NCT01898273 2015-09-09

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Phase 2 Terminated

Disease, Glioblastoma, Glioma

NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase 2 Completed

98 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00571675 2010-11-09

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

Disease, Neoplasm Metastasis, Prostatic Neoplasms